TB-500 10mg Pen – Advanced Research Peptide
The TB-500 10mg Pen provides researchers with a convenient pre-filled research format containing TB-500, a synthetic peptide associated with a fragment of thymosin beta-4.
Designed for controlled laboratory environments, the TB-500 10mg Pen offers an alternative presentation to conventional peptide containers. Its pre-filled format can simplify inventory organization and reduce the number of separate preparation components required during laboratory workflows.
TB-500 is frequently described in scientific and analytical literature in connection with the N-terminally acetylated seven-amino-acid fragment Ac-LKKTETQ, corresponding to residues 17–23 of thymosin beta-4. However, the name “TB-500” has been used inconsistently for related substances, making precise chemical identity and batch documentation particularly important.
The TB-500 10mg Pen is supplied strictly as a research product. It is not intended for human consumption, therapeutic use, or veterinary use.
What Is the TB-500 10mg Pen?
The TB-500 10mg Pen is a pre-filled research-format presentation containing a labelled quantity of TB-500.
TB-500 is generally associated with a synthetic fragment of thymosin beta-4 rather than full-length thymosin beta-4 itself. Scientific literature has identified the sequence LKKTETQ as the actin-binding region within thymosin beta-4, while analytical work has identified N-terminally acetylated LKKTETQ in products described as TB-500.
This distinction is important.
TB-500 should not automatically be described as identical to full-length thymosin beta-4.
Full-length thymosin beta-4 is a 43-amino-acid protein, whereas TB-500 is generally associated with a much shorter synthetic fragment. Research involving full-length thymosin beta-4 therefore should not automatically be interpreted as evidence for an equivalent effect from every TB-500 preparation.
For researchers, this makes analytical characterization and accurate product identification important parts of laboratory work.
Why Choose a TB-500 10mg Pen?
The TB-500 10mg Pen provides a different product format from a conventional research vial.
A pre-filled presentation can offer several organizational advantages for laboratories that prefer standardized product formats.
Convenient Research Format
The pen presentation provides a compact format that can be easier to organize within a controlled laboratory environment.
Reduced Preparation Components
Compared with conventional lyophilized vial presentations, a pre-filled format may reduce the number of separate components associated with laboratory preparation.
Simplified Inventory Management
The clearly labelled 10mg format provides an easily identifiable research product for inventory systems.
Consistent Product Presentation
Using a standardized presentation can help laboratories maintain consistent handling and documentation practices across research projects.
Compact Storage
The pen format can provide a convenient alternative when laboratory storage space and organization are important considerations.
TB-500 Pen vs. TB-500 Vial
Both pen and vial presentations can be used as research-product formats, but their physical presentation and handling requirements can differ.
| Feature | TB-500 10mg Pen | TB-500 Vial |
|---|---|---|
| Presentation | Pre-filled research format | Conventional research container |
| Labelled quantity | 10mg | Product-specific |
| Preparation | Format-dependent | May require laboratory preparation |
| Storage | Follow product-specific requirements | Follow product-specific requirements |
| Handling | Compact research format | Conventional laboratory format |
| Inventory | Easy to identify and organize | Familiar vial-based inventory |
| Documentation | Batch/product documentation recommended | Batch/product documentation recommended |
The appropriate format depends on the laboratory’s equipment, workflow, storage requirements, and research protocol.
Importantly, the TB-500 10mg Pen should not automatically be assumed to have identical formulation characteristics to a separate TB-500 vial simply because both products use the TB-500 name.
Understanding TB-500 and Thymosin Beta-4
Thymosin beta-4 is a naturally occurring 43-amino-acid peptide associated with actin regulation and cellular processes including migration and tissue biology.
Researchers have identified several biologically active regions within thymosin beta-4. One important region is the sequence LKKTETQ, corresponding to amino acids 17–23, which is associated with actin binding.
TB-500 is generally associated with a synthetic version of this short region.
A 2012 analytical study identified N-terminally acetylated LKKTETQ in material described as TB-500 and developed analytical methods for identifying the compound and its metabolites.
This makes TB-500 particularly interesting from a peptide chemistry and analytical research perspective.
TB-500 10mg Pen and Actin-Related Research
Actin is an important structural protein involved in numerous cellular processes.
The actin cytoskeleton contributes to:
- Cell shape
- Cell movement
- Intracellular organization
- Mechanical signalling
- Cellular migration
- Structural organization
- Tissue-associated cellular processes
The LKKTETQ region of thymosin beta-4 has been studied in connection with actin binding. Consequently, researchers investigating TB-500 may be interested in the relationship between this peptide sequence and actin-associated cellular pathways.
The TB-500 10mg Pen can therefore be positioned as a research material for studies involving peptide structure, actin biology, and cellular signalling.
Cellular Migration Research
Cellular migration is an important area of biological research.
Cells move in response to chemical, mechanical, and structural signals. Migration plays roles in numerous biological processes, making the underlying mechanisms an important subject of laboratory investigation.
Thymosin beta-4 research has investigated the relationship between its actin-binding region and cell migration. However, findings involving full-length thymosin beta-4 should not automatically be interpreted as evidence for every TB-500 formulation.
This distinction is particularly important when creating scientific product descriptions.
The TB-500 10mg Pen is therefore best described in terms of research into cellular migration and actin-associated biology, rather than making therapeutic claims about tissue repair.
Connective Tissue Research
Connective tissue biology involves complex interactions among cells, extracellular matrix components, structural proteins, signalling molecules, and mechanical forces.
Researchers studying connective tissue may investigate:
- Cell migration
- Extracellular matrix organization
- Cytoskeletal activity
- Fibroblast biology
- Structural protein regulation
- Cellular signalling
- Tissue-associated molecular pathways
Thymosin beta-4-derived sequences have attracted scientific interest in these areas, particularly because of their relationship with actin-associated cellular processes.
The TB-500 10mg Pen can therefore be relevant to laboratory investigations examining peptide interactions and connective-tissue-associated cellular biology.
TB-500 and Angiogenesis Research
Angiogenesis refers to the formation of new blood vessels from existing vascular structures.
Research involving thymosin beta-4 has investigated relationships between thymosin beta-4-derived sequences, endothelial cell behaviour, vascular signalling, and angiogenesis.
However, evidence involving full-length thymosin beta-4 should be distinguished from evidence specifically examining TB-500.
Some older research investigated synthetic peptides corresponding to the LKKTETQ region in experimental wound models, while more recent analytical research has highlighted uncertainty about whether reported biological activity attributed directly to TB-500 may instead involve metabolites.
This makes TB-500 an interesting subject for continued analytical and mechanistic research.
TB-500 10mg and Peptide Chemistry
From a peptide chemistry perspective, TB-500 provides an interesting example of how a short peptide fragment can be investigated separately from its parent molecule.
Full-length thymosin beta-4 contains 43 amino acids.
The commonly described TB-500 structure is considerably shorter and is associated with the N-terminally acetylated sequence:
Ac-LKKTETQ
This is important because peptide length, terminal modification, sequence, conformation, purity, and aggregation behaviour can all affect analytical characterization.
FDA materials also highlight the importance of precise identity for TB-500-related substances because different salts and derivatives may be sold under the same common name.
For researchers, batch documentation therefore matters.
Analytical Research With TB-500
Analytical characterization is an important component of peptide research.
Researchers may use analytical techniques to investigate:
- Molecular identity
- Purity
- Peptide-related impurities
- Degradation products
- Metabolites
- Batch consistency
- Chemical modifications
- Stability
- Aggregation
- Chromatographic behaviour
Published research has demonstrated the use of liquid chromatography and mass spectrometry to identify and analyze TB-500 and related metabolites.
This makes the TB-500 10mg Pen potentially useful as a research material where analytical characterization forms part of the experimental workflow.
Importance of Batch Documentation
Because TB-500 is a common name rather than a standardized United States Adopted Name, accurate documentation is particularly important.
FDA materials specifically note that different substances, salts, and derivatives may be marketed under the TB-500 name.
For research purposes, laboratories should maintain appropriate documentation regarding:
- Product identity
- Batch number
- Labelled quantity
- Manufacturing information
- Analytical testing
- Purity specifications
- Storage requirements
- Expiration or retest information where applicable
The exact documentation available should correspond to the actual product supplied.
Quality Standards
The TB-500 10mg Pen should be supported by appropriate quality-control documentation for laboratory research.
Important quality considerations can include:
- Verified product identity
- Batch traceability
- Purity testing
- Analytical characterization
- Consistent formulation
- Appropriate packaging
- Storage information
- Lot documentation
Where analytical testing is provided, laboratories should review the actual batch-specific documentation rather than relying solely on generalized product claims.
Quality assurance is particularly important for research peptides because small differences in sequence, modification, impurities, or formulation can influence experimental results.
TB-500 10mg Pen and Research Reproducibility
Reproducibility is one of the most important principles in scientific research.
A research experiment should ideally be performed using materials that are adequately characterized and documented.
Consistent product presentation can help laboratories standardize their inventory and documentation procedures.
The TB-500 10mg Pen may therefore be useful for research environments where researchers prefer a compact, standardized presentation.
However, product format alone does not guarantee experimental reproducibility.
Researchers should also consider:
- Peptide identity
- Purity
- Experimental conditions
- Analytical methods
- Sample handling
- Storage
- Equipment
- Environmental variables
- Batch-to-batch differences
Storage and Handling
The TB-500 10mg Pen should be stored according to the specific manufacturer’s product documentation.
Storage conditions can vary depending on the formulation, container, and stability characteristics of the product.
Researchers should avoid exposing peptide materials unnecessarily to:
- Excessive heat
- Direct sunlight
- Moisture
- Contamination
- Repeated temperature fluctuations
- Uncontrolled storage conditions
The original packaging and product documentation should be retained whenever possible.
For research materials, appropriate storage and handling procedures are important for maintaining sample integrity.
Pre-Filled Research Format
One of the distinguishing features of the TB-500 10mg Pen is its pre-filled presentation.
This format is designed for researchers who prefer a compact product presentation rather than a conventional research vial.
The pre-filled format may simplify organizational tasks by reducing the number of separate components associated with the product.
It can also make inventory identification easier because the labelled product remains contained within its dedicated presentation.
However, the pen should be treated as a research-format container, not as an indication of approved medical use.
Why Research Laboratories May Prefer a Pen Format
Different laboratories have different workflow preferences.
Some researchers prefer traditional vials because they provide flexibility within laboratory protocols.
Others may prefer pre-filled formats because they offer:
- Compact organization
- Simple inventory tracking
- Reduced preparation components
- Convenient storage
- Clearly defined product quantities
- Consistent presentation
The TB-500 10mg Pen is intended to provide this type of convenient research presentation.
TB-500 Research Applications
Research involving TB-500 or thymosin beta-4-derived sequences can involve several scientific areas.
Potential research categories include:
Peptide Chemistry
Investigating sequence, structure, modifications, purity, and degradation.
Actin Biology
Studying peptide relationships with actin-associated cellular processes.
Cellular Migration
Investigating mechanisms involved in cell movement.
Connective Tissue Biology
Examining cellular and molecular processes associated with connective tissues.
Vascular Biology
Studying endothelial and angiogenesis-related pathways.
Analytical Chemistry
Developing methods for peptide detection and characterization.
Metabolism and Biotransformation
Investigating TB-500 metabolites and degradation products.
These areas represent research topics, not established therapeutic applications.
Current Research Limitations
The scientific literature surrounding TB-500 should be interpreted carefully.
Research involving full-length thymosin beta-4 is substantially broader than research specifically involving TB-500.
A 2024 analytical study investigated TB-500 and its metabolites and noted that previously reported wound-healing activity attributed to TB-500 may potentially involve metabolites rather than the parent compound itself.
FDA materials also state that it has not identified human exposure data for drug products containing thymosin beta-4 fragment (TB-500) and identifies concerns involving immunogenicity, aggregation, and peptide-related impurities.
Accordingly, the TB-500 10mg Pen should not be marketed as a proven treatment or as having established clinical benefits.
Regulatory Considerations
TB-500 is not an FDA-approved therapeutic product.
In 2026, FDA materials specifically reviewed TB-500-related bulk substances in the context of a Pharmacy Compounding Advisory Committee discussion. FDA’s materials identify TB-500 as a thymosin beta-4 fragment and discuss concerns regarding chemical characterization and safety information.
This reinforces the importance of distinguishing laboratory research materials from approved pharmaceutical products.
The TB-500 10mg Pen is therefore presented exclusively as a research product.
Important Distinction: TB-500 vs. Thymosin Beta-4
It is important not to use the terms TB-500 and thymosin beta-4 interchangeably.
Thymosin beta-4 is a naturally occurring 43-amino-acid peptide.
TB-500 is generally associated with a synthetic fragment corresponding to the actin-binding region of thymosin beta-4.
Research findings involving one compound cannot automatically be transferred to the other.
This distinction is especially important for scientific product descriptions, analytical work, and experimental interpretation.
Product Specifications
Product Name: TB-500 10mg Pen
Product Type: Research peptide
Format: Pre-filled research pen
Labelled Quantity: 10mg
Compound: TB-500
Associated Peptide: Thymosin beta-4 fragment
Commonly Described Sequence: Ac-LKKTETQ
Research Areas: Peptide chemistry, actin biology, cellular migration, connective tissue biology, analytical research and related laboratory studies
Intended Use: Laboratory research and analytical testing only
Human Use: Not intended
Veterinary Use: Not intended
Storage: Follow product-specific storage instructions
Frequently Asked Questions
What is a TB-500 10mg Pen?
The TB-500 10mg Pen is a pre-filled research-format product containing a labelled 10mg quantity of TB-500 for laboratory research and analytical applications.
What is TB-500?
TB-500 is generally associated with a synthetic fragment of thymosin beta-4. FDA materials identify TB-500 as the N-acetylated seven-amino-acid fragment associated with residues 17–23 of thymosin beta-4.
Is TB-500 the same as full-length thymosin beta-4?
No. Full-length thymosin beta-4 is a 43-amino-acid peptide, while TB-500 is associated with a much shorter fragment.
What is the commonly reported TB-500 sequence?
TB-500 is commonly described as the N-terminally acetylated sequence Ac-LKKTETQ. Analytical research has identified this compound in material described as TB-500.
Why is TB-500 researched?
TB-500 and related thymosin beta-4-derived sequences have been investigated in areas including actin biology, cellular migration, connective tissue biology, vascular research, peptide chemistry, and analytical characterization.
Is the TB-500 10mg Pen intended for human use?
No. The TB-500 10mg Pen is supplied for laboratory research and analytical testing only and is not intended for human use.
Is TB-500 FDA approved?
TB-500 is not an FDA-approved therapeutic product. FDA materials have discussed TB-500-related substances in the context of compounding evaluation and identified important safety and characterization uncertainties.
Does TB-500 contain full-length thymosin beta-4?
TB-500 should not be described as full-length thymosin beta-4. It is generally associated with a short synthetic fragment of the parent peptide.
Why is analytical testing important for TB-500?
The TB-500 name has been used for related substances and derivatives, making accurate chemical identity, purity, and batch documentation important for research reproducibility.
What research areas are associated with TB-500?
Research areas include actin-associated biology, cellular migration, connective tissue research, vascular biology, peptide chemistry, metabolism, and analytical testing.
How should the TB-500 10mg Pen be stored?
Follow the storage requirements supplied with the specific product. Avoid uncontrolled temperature, moisture, direct sunlight, and unnecessary environmental exposure.
Research Use Only
The TB-500 10mg Pen is supplied strictly for laboratory research, scientific investigation, analytical testing, and other appropriate research applications.
This product is not intended for human consumption, human administration, therapeutic use, or veterinary use.
The information provided on this page is intended for scientific and product-description purposes and should not be interpreted as medical advice or a recommendation for human use.
Researchers and qualified laboratory personnel are responsible for following applicable laws, institutional requirements, laboratory safety procedures, manufacturer documentation, and appropriate handling practices.
Final Product Overview
The TB-500 10mg Pen provides a convenient pre-filled research format for laboratories investigating TB-500 and related thymosin beta-4 fragment biology.
TB-500 is associated with the synthetic peptide sequence Ac-LKKTETQ and has attracted research interest because of its relationship to the actin-binding region of thymosin beta-4. Research areas include cellular migration, actin-associated pathways, connective tissue biology, vascular research, peptide chemistry, and analytical characterization.
At the same time, TB-500 should be distinguished carefully from full-length thymosin beta-4, and researchers should consider the limitations of the current evidence base.
With its compact pre-filled presentation, clearly defined 10mg format, and research-focused positioning, the TB-500 10mg Pen is designed as a convenient option for controlled laboratory research environments.
For research use only. Not for human or veterinary use.
